Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App





Mobile Real Time PCR Device Enables COVID-19 Detection in Near-Patient Setting

By LabMedica International staff writers
Posted on 01 Aug 2022

A mobile real time PCR device can expand COVID-19 testing capacity and enable pathogen detection with a multiplex assay at high speed, in addition to offering simplicity of use.

Ubiquitome Limited (Auckland, New Zealand) has unveiled its new COVID PCR testing tool named Liberty16 Pro that allows workplaces of up to 500 employees to conduct COVID-testing efficiently with a single, real time PCR device. Surveillance testing at onsite locations can give better early warning, as well as potentially being more cost effective than rapid antigen tests. Liberty16 Pro is an advanced version of Ubiquitome’s Liberty16 mobile real time PCR device which has FDA emergency use authorization for use with the Yale School of Public Health SalivaDirect SARS-CoV-2 assay for diagnostic purposes at certain designated CLIA laboratories.

The Liberty16 mobile PCR system had allowed workplaces to instigate surveillance - checking patients pre-admission, monitoring staff, splitting teams into shifts, and keeping vital supply chain services running. After training by Ubiquitome, many companies and organizations set up dedicated rooms on site and interpret sample results with ease through Ubiquitome's proprietary mobile phone app. Ubiquitome has now developed an advanced version of Liberty16 to expand testing capacity and enable pathogen detection with a multiplex assay and even greater speed - while retaining the existing simplicity of use. The Liberty16 and Liberty16 Pro are research use only devices, not for diagnostic purposes.

"The need for diagnostics that advance clinical care and public health has never been greater with the mutation of Omicron variants picking up speed," said Dr. Paul Pickering, Ubiquitome's CEO. "Developments in the Liberty16 Pro potentially expand testing capacity without sacrificing the assay's detection sensitivity, while further reducing test consumable costs and retaining the unique features which are best fit to a near-patient setting."

Related Links:
Ubiquitome Limited 

Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Magnetic Bead Separation Modules
MAG and HEATMAG
POCT Fluorescent Immunoassay Analyzer
FIA Go
Gold Member
SARS-CoV-2 RT-PCR Assay
Reliance SARS-CoV-2 RT-PCR Assay Kit
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get complete access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: The 3D printed miniature ionizer is a key component of a mass spectrometer (Photo courtesy of MIT)

3D Printed Point-Of-Care Mass Spectrometer Outperforms State-Of-The-Art Models

Mass spectrometry is a precise technique for identifying the chemical components of a sample and has significant potential for monitoring chronic illness health states, such as measuring hormone levels... Read more

Hematology

view channel
Image: The CAPILLARYS 3 DBS devices have received U.S. FDA 510(k) clearance (Photo courtesy of Sebia)

Next Generation Instrument Screens for Hemoglobin Disorders in Newborns

Hemoglobinopathies, the most widespread inherited conditions globally, affect about 7% of the population as carriers, with 2.7% of newborns being born with these conditions. The spectrum of clinical manifestations... Read more

Immunology

view channel
Image: The AI predictive model identifies the most potent cancer killing immune cells for use in immunotherapies (Photo courtesy of Shutterstock)

AI Predicts Tumor-Killing Cells with High Accuracy

Cellular immunotherapy involves extracting immune cells from a patient's tumor, potentially enhancing their cancer-fighting capabilities through engineering, and then expanding and reintroducing them into the body.... Read more

Microbiology

view channel
Image: The T-SPOT.TB test is now paired with the Auto-Pure 2400 liquid handling platform for accurate TB testing (Photo courtesy of Shutterstock)

Integrated Solution Ushers New Era of Automated Tuberculosis Testing

Tuberculosis (TB) is responsible for 1.3 million deaths every year, positioning it as one of the top killers globally due to a single infectious agent. In 2022, around 10.6 million people were diagnosed... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.